Learn more

MSD KK

Overview
  • Total Patents
    191
  • GoodIP Patent Rank
    232,857
About

MSD KK has a total of 191 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ASTRAEA THERAPEUTICS LLC, AKADIA FARMAS JUTIKALZ INK and FLYNN DANIEL L.

Patent filings per year

Chart showing MSD KKs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bamba Makoto 26
#2 Sato Nagaaki 26
#3 Takahashi Keiji 24
#4 Sunami Satoshi 24
#5 Kawanishi Nobuhiko 23
#6 Nishimura Teruyuki 22
#7 Sakamoto Toshihiro 22
#8 Ohkubo Mitsuru 21
#9 Yoshizumi Takashi 20
#10 Yamamoto Fuyuki 20

Latest patents

Publication Filing date Title
JP2015026233A Server device helping user adhere to dosing
EP2424860A1 Heteroarylthiomethyl pyridine derivative
EP2424861A1 Indole-2-carboxamide derivative
EP2448921A1 Aryl indole derivatives
EP2411012A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
CA2755806A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
US2011312976A1 Isoindolin-1-one derivative
US2011275647A1 Pyrimidin-4-(3h)-one derivatives
EP2401281A1 Pyrimidopyrimidoindazole derivative
EP2398781A1 1,4-benzodiazepin-2-on derivatives
EP2389366A1 Benzodiazepin-2-on derivatives
EP2376494A1 Dihydropyrimidopyrimidine derivatives
AU2009325398A1 Dihydropyrimidopyrimidine derivative
EP2319841A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
AU2009266730A1 Novel spirochromanone carboxylic acids
AU2009255183A1 Novel isoxazole derivative
AU2009255358A1 Inhibitors of Akt activity
EP2280001A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
AU2008308092A1 Benzoxazinone derivative
NZ581936A Bicycloaniline derivatives